Praxair (PX) Reports In-Line Q4 EPS

Go back to Praxair (PX) Reports In-Line Q4 EPS

JPMorgan Downgrades P10 Inc (PX) to Neutral

March 1, 2024 5:43 AM EST

JPMorgan analyst Kenneth B. Worthington downgraded P10 Inc (NYSE: PX) from Overweight to Neutral with a price target of $9.50 (from $15.50).

The analyst comments "We are downgrading P10 to Neutral from Overweight. New CEO Luke Sarsfield has come out with his priorities that... More